Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 38% ± 13% | |
peripheral blood | 17 studies | 33% ± 12% | |
intestine | 10 studies | 35% ± 12% | |
eye | 9 studies | 46% ± 22% | |
kidney | 8 studies | 37% ± 6% | |
brain | 7 studies | 27% ± 8% | |
bone marrow | 5 studies | 23% ± 6% | |
uterus | 5 studies | 49% ± 13% | |
liver | 5 studies | 44% ± 19% | |
pancreas | 4 studies | 55% ± 27% | |
placenta | 4 studies | 29% ± 6% | |
prostate | 4 studies | 53% ± 13% | |
lymph node | 4 studies | 25% ± 6% | |
breast | 4 studies | 50% ± 5% | |
adrenal gland | 3 studies | 38% ± 12% | |
esophagus | 3 studies | 40% ± 16% | |
skin | 3 studies | 46% ± 14% | |
thymus | 3 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3297.78 | 258 / 258 | 100% | 109.76 | 230 / 230 |
esophagus | 100% | 2240.30 | 1445 / 1445 | 100% | 49.41 | 183 / 183 |
kidney | 100% | 2516.91 | 89 / 89 | 100% | 58.58 | 901 / 901 |
liver | 100% | 2601.62 | 226 / 226 | 100% | 55.87 | 406 / 406 |
lung | 100% | 2659.35 | 578 / 578 | 100% | 59.33 | 1155 / 1155 |
ovary | 100% | 3209.21 | 180 / 180 | 100% | 55.93 | 430 / 430 |
pancreas | 100% | 1910.68 | 328 / 328 | 100% | 56.34 | 178 / 178 |
stomach | 100% | 2090.16 | 359 / 359 | 100% | 54.95 | 286 / 286 |
uterus | 100% | 2035.35 | 170 / 170 | 100% | 68.94 | 459 / 459 |
brain | 100% | 2890.77 | 2641 / 2642 | 100% | 123.93 | 705 / 705 |
thymus | 100% | 3158.56 | 653 / 653 | 100% | 95.05 | 604 / 605 |
skin | 100% | 1512.44 | 1803 / 1809 | 100% | 67.42 | 472 / 472 |
intestine | 100% | 2359.05 | 966 / 966 | 100% | 56.10 | 525 / 527 |
bladder | 100% | 2344.05 | 21 / 21 | 99% | 62.09 | 501 / 504 |
prostate | 100% | 2387.98 | 244 / 245 | 100% | 80.04 | 500 / 502 |
breast | 100% | 2398.40 | 459 / 459 | 99% | 61.39 | 1107 / 1118 |
blood vessel | 100% | 3309.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 66.78 | 29 / 29 |
muscle | 100% | 3573.50 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2109.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.57 | 1 / 1 |
adipose | 100% | 2474.30 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 100% | 3737.68 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1632.56 | 911 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 29.24 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1990266 | Biological process | neutrophil migration |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0010742 | Biological process | macrophage derived foam cell differentiation |
GO_0042098 | Biological process | T cell proliferation |
GO_0045728 | Biological process | respiratory burst after phagocytosis |
GO_0051223 | Biological process | regulation of protein transport |
GO_0051649 | Biological process | establishment of localization in cell |
GO_1902624 | Biological process | positive regulation of neutrophil migration |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0071639 | Biological process | positive regulation of monocyte chemotactic protein-1 production |
GO_0018345 | Biological process | protein palmitoylation |
GO_2000406 | Biological process | positive regulation of T cell migration |
GO_0072678 | Biological process | T cell migration |
GO_0006979 | Biological process | response to oxidative stress |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0006816 | Biological process | calcium ion transport |
GO_0032469 | Biological process | endoplasmic reticulum calcium ion homeostasis |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SELENOK |
Protein name | Selenoprotein K (SelK) Selenoprotein K |
Synonyms | HSPC297 HSPC030 SELK hCG_1641209 |
Description | FUNCTION: Required for Ca(2+) flux in immune cells and plays a role in T-cell proliferation and in T-cell and neutrophil migration (By similarity). Involved in endoplasmic reticulum-associated degradation (ERAD) of soluble glycosylated proteins . Required for palmitoylation and cell surface expression of CD36 and involved in macrophage uptake of low-density lipoprotein and in foam cell formation (By similarity). Together with ZDHHC6, required for palmitoylation of ITPR1 in immune cells, leading to regulate ITPR1 stability and function . Plays a role in protection of cells from ER stress-induced apoptosis . Protects cells from oxidative stress when overexpressed in cardiomyocytes . . |
Accessions | ENST00000495461.6 F8WAX7 A8K0M9 Q9Y6D0 ENST00000488746.1 |